<p>俄亥俄州公共雇员退休系统在其最近向证券交易委员会提交的 13F 文件中表示，在第四季度将其在西方制药服务公司（NYSE:WST - 免费报告）的股份减少了 10.9%。该机构投资者在此期间出售了 3,722 股后，持有 30,459 股该医疗器械供应商的股票。根据其最近的 SEC 文件，俄亥俄州公共雇员退休系统在西方制药服务公司的持股价值为 9,977,000 美元。</p>
<ul>
<li>3 只有潜力增加股息的股息冠军</li>
</ul>
<p>其他大型投资者也买卖了该公司的股票。Whipplewood Advisors LLC 在第四季度以 25,000 美元的估值购买了西方制药服务的新头寸。Centricity Wealth Management LLC 在第四季度以 35,000 美元的估值购买了西方制药服务的股份。Cornerstone Planning Group LLC 在第四季度将其在西方制药服务的股份增加了 57.1%。Cornerstone Planning Group LLC 现在拥有 110 股该医疗器械供应商的股票，价值 38,000 美元，此前在上个季度又购买了 40 股。IFP Advisors Inc 在第四季度将其在西方制药服务的股份增加了 150.9%。IFP Advisors Inc 现在拥有 133 股该医疗器械供应商的股票，价值 45,000 美元，此前在上个季度又购买了 80 股。最后，Private Trust Co. NA 在第四季度将其在西方制药服务的股份增加了 138.6%。Private Trust Co. NA 现在拥有 136 股该医疗器械供应商的股票，价值 45,000 美元，此前在上个季度又购买了 79 股。目前 93.90% 的股票由机构投资者持有。</p>
<h2>西方制药服务股价下跌 1.4%</h2>
<p>周二，WST 的股价开盘为 205.67 美元。该公司的 50 日移动平均线为 212.63 美元，200 日移动平均线为 269.89 美元。西方制药服务公司 52 周低点为 187.43 美元，52 周高点为 352.33 美元。该公司的市值为 147.8 亿美元，市盈率为 30.74，市盈增长比率为 6.74，贝塔值为 1.14。该公司的债务与股本比率为 0.08，速动比率为 2.23，流动比率为 2.79。</p>
<ul>
<li>今年将推动 S&amp;P 500 表现的因素是什么？</li>
</ul>
<p>西方制药服务（NYSE:WST - 获取免费报告）最近一次发布财报是在 4 月 24 日，周四。该医疗器械供应商报告本季度每股收益为 1.45 美元，超出分析师一致预期的 1.22 美元，超出幅度为 0.23 美元。该公司本季度的收入为 6.98 亿美元，而分析师预期为 6.8524 亿美元。西方制药服务的股本回报率为 18.60%，净利润率为 17.03%。该公司的季度收入较去年同期增长了 0.4%。在去年同期，该公司每股收益为 1.56 美元。整体来看，研究分析师预测西方制药服务公司今年将发布 6.62 美元的每股收益。</p>
<h2>西方制药服务股息公告</h2>
<p>该公司最近还宣布了一项季度股息，将于 8 月 6 日（星期三）支付。7 月 30 日（星期三）登记的股东将获得每股 0.21 美元的股息。这相当于年化股息为 0.84 美元，收益率为 0.41%。除息日期为 7 月 30 日（星期三）。西方制药服务的派息比率目前为 13.19%。</p>
<h2>分析师评级变动</h2>
<ul>
<li>至少有 30 年股息增长的医疗保健股票</li>
</ul>
<p>WST 已成为几份研究分析师报告的主题。Stephens 在 4 月 21 日（星期一）的研究报告中将西方制药服务的评级上调至 “强力买入”。华尔街 Zen 在 2 月 27 日（星期四）的研究报告中将西方制药服务的评级从 “买入” 下调至 “持有”。花旗集团在周四的研究报告中重申了对西方制药服务股票的 “买入” 评级。Evercore ISI 在 3 月 18 日（星期二）的研究报告中开始覆盖西方制药服务，并为该公司设定了 “跑赢大盘” 的评级和 275.00 美元的目标价。最后，KeyCorp 在 2 月 14 日（星期五）的研究报告中将西方制药服务的目标价从 470.00 美元下调至 325.00 美元，并为该公司设定了 “增持” 评级。两位投资分析师对该股票给予了 “持有” 评级，六位给予了 “买入” 评级，一位给予了 “强力买入” 评级。根据 MarketBeat.com 的数据，西方制药服务目前的平均评级为 “适度买入”，平均目标价为 332.50 美元。</p>
<p><strong>查看我们对西方制药服务的最新分析</strong></p>
<h2>西方制药服务公司简介</h2>
<p>（免费报告）</p>
<p>西方制药服务公司设计、制造和销售用于注射药物和医疗产品的封闭和输送系统，业务覆盖美洲、欧洲、中东、非洲和亚太地区。该公司分为两个部门，专有产品和合同制造产品。</p>
<h2>另见</h2>
<ul>
<li>五只我们更看好的股票，胜过西方制药服务</li>
<li>投资石油股票的方式和原因</li>
<li>Workday 股价暴跌：对 AI 投资者来说是自动买入</li>
<li>上升趋势股票解析：学习如何利用上升趋势进行交易</li>
<li>MercadoLibre 股价飙升——你应该等待更好的入场时机吗？</li>
<li>专家股票交易心理技巧</li>
<li>对市场有疑虑？3 只股票可应对恐惧、不确定性和怀疑</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVdTVA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVdTVA"/></p>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，旨在为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。请将有关此故事的任何问题或评论发送至 contact@marketbeat.com.</em></p>
<h2>你现在应该投资 1,000 美元在西氏医药服务吗？</h2>
<p>在考虑西氏医药服务之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只股票，顶级分析师正在悄悄地向客户推荐在更广泛的市场注意到之前购买……而西氏医药服务并不在名单上。</p>
<p>虽然西氏医药服务目前在分析师中获得了买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

西氏医药服务

<p>俄亥俄州公共雇员退休系统减少了对西氏医药服务公司（NYSE:WST）10.9% 的持股，在第四季度出售了 3,722 股，剩余持股为 30,459 股，价值约为 998 万美元。其他投资者也调整了在该公司的持仓。西氏医药的股票开盘价为 205.67 美元，市值为 147.8 亿美元，市盈率为 30.74。该公司最近报告每股收益为 1.45 美元，超出预期，并宣布季度股息为每股 0.21 美元</p>

<p>Public Employees Retirement System of Ohio cut its stake in shares of West Pharmaceutical Services, Inc. (NYSE:WST - Free Report) by 10.9% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 30,459 shares of the medical instruments supplier's stock after selling 3,722 shares during the period. Public Employees Retirement System of Ohio's holdings in West Pharmaceutical Services were worth $9,977,000 as of its most recent SEC filing.</p>
<div class="lb-trans"><p>俄亥俄州公共雇员退休系统在其最近向证券交易委员会提交的 13F 文件中表示，在第四季度将其在西方制药服务公司（NYSE:WST - 免费报告）的股份减少了 10.9%。该机构投资者在此期间出售了 3,722 股后，持有 30,459 股该医疗器械供应商的股票。根据其最近的 SEC 文件，俄亥俄州公共雇员退休系统在西方制药服务公司的持股价值为 9,977,000 美元。</p>
</div><ul>
<li>3 Dividend Champions with room for dividend growth</li>
</ul>
<div class="lb-trans"><ul>
<li>3 只有潜力增加股息的股息冠军</li>
</ul>
</div><p>Other large investors have also bought and sold shares of the company. Whipplewood Advisors LLC bought a new position in West Pharmaceutical Services during the 4th quarter valued at $25,000. Centricity Wealth Management LLC purchased a new stake in shares of West Pharmaceutical Services during the 4th quarter valued at $35,000. Cornerstone Planning Group LLC increased its position in shares of West Pharmaceutical Services by 57.1% during the 4th quarter. Cornerstone Planning Group LLC now owns 110 shares of the medical instruments supplier's stock valued at $38,000 after purchasing an additional 40 shares during the last quarter. IFP Advisors Inc increased its position in shares of West Pharmaceutical Services by 150.9% during the 4th quarter. IFP Advisors Inc now owns 133 shares of the medical instruments supplier's stock valued at $45,000 after purchasing an additional 80 shares during the last quarter. Finally, Private Trust Co. NA increased its position in shares of West Pharmaceutical Services by 138.6% during the 4th quarter. Private Trust Co. NA now owns 136 shares of the medical instruments supplier's stock valued at $45,000 after purchasing an additional 79 shares during the last quarter. 93.90% of the stock is currently owned by institutional investors.</p>
<div class="lb-trans"><p>其他大型投资者也买卖了该公司的股票。Whipplewood Advisors LLC 在第四季度以 25,000 美元的估值购买了西方制药服务的新头寸。Centricity Wealth Management LLC 在第四季度以 35,000 美元的估值购买了西方制药服务的股份。Cornerstone Planning Group LLC 在第四季度将其在西方制药服务的股份增加了 57.1%。Cornerstone Planning Group LLC 现在拥有 110 股该医疗器械供应商的股票，价值 38,000 美元，此前在上个季度又购买了 40 股。IFP Advisors Inc 在第四季度将其在西方制药服务的股份增加了 150.9%。IFP Advisors Inc 现在拥有 133 股该医疗器械供应商的股票，价值 45,000 美元，此前在上个季度又购买了 80 股。最后，Private Trust Co. NA 在第四季度将其在西方制药服务的股份增加了 138.6%。Private Trust Co. NA 现在拥有 136 股该医疗器械供应商的股票，价值 45,000 美元，此前在上个季度又购买了 79 股。目前 93.90% 的股票由机构投资者持有。</p>
</div><h2>West Pharmaceutical Services Trading Down 1.4%</h2>
<div class="lb-trans"><h2>西方制药服务股价下跌 1.4%</h2>
</div><p>Shares of WST opened at $205.67 on Tuesday. The business has a 50-day moving average of $212.63 and a 200 day moving average of $269.89. West Pharmaceutical Services, Inc. has a fifty-two week low of $187.43 and a fifty-two week high of $352.33. The firm has a market cap of $14.78 billion, a P/E ratio of 30.74, a price-to-earnings-growth ratio of 6.74 and a beta of 1.14. The company has a debt-to-equity ratio of 0.08, a quick ratio of 2.23 and a current ratio of 2.79.</p>
<div class="lb-trans"><p>周二，WST 的股价开盘为 205.67 美元。该公司的 50 日移动平均线为 212.63 美元，200 日移动平均线为 269.89 美元。西方制药服务公司 52 周低点为 187.43 美元，52 周高点为 352.33 美元。该公司的市值为 147.8 亿美元，市盈率为 30.74，市盈增长比率为 6.74，贝塔值为 1.14。该公司的债务与股本比率为 0.08，速动比率为 2.23，流动比率为 2.79。</p>
</div><ul>
<li>What Factors Will Drive S&amp;P 500 Performance This Year?</li>
</ul>
<div class="lb-trans"><ul>
<li>今年将推动 S&amp;P 500 表现的因素是什么？</li>
</ul>
</div><p>West Pharmaceutical Services (NYSE:WST - Get Free Report) last posted its earnings results on Thursday, April 24th. The medical instruments supplier reported $1.45 earnings per share for the quarter, beating analysts' consensus estimates of $1.22 by $0.23. The business had revenue of $698.00 million during the quarter, compared to analyst estimates of $685.24 million. West Pharmaceutical Services had a return on equity of 18.60% and a net margin of 17.03%. The company's quarterly revenue was up .4% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $1.56 EPS. As a group, research analysts forecast that West Pharmaceutical Services, Inc. will post 6.62 EPS for the current year.</p>
<div class="lb-trans"><p>西方制药服务（NYSE:WST - 获取免费报告）最近一次发布财报是在 4 月 24 日，周四。该医疗器械供应商报告本季度每股收益为 1.45 美元，超出分析师一致预期的 1.22 美元，超出幅度为 0.23 美元。该公司本季度的收入为 6.98 亿美元，而分析师预期为 6.8524 亿美元。西方制药服务的股本回报率为 18.60%，净利润率为 17.03%。该公司的季度收入较去年同期增长了 0.4%。在去年同期，该公司每股收益为 1.56 美元。整体来看，研究分析师预测西方制药服务公司今年将发布 6.62 美元的每股收益。</p>
</div><h2>West Pharmaceutical Services Dividend Announcement</h2>
<div class="lb-trans"><h2>西方制药服务股息公告</h2>
</div><p>The business also recently announced a quarterly dividend, which will be paid on Wednesday, August 6th. Shareholders of record on Wednesday, July 30th will be issued a dividend of $0.21 per share. This represents a $0.84 dividend on an annualized basis and a yield of 0.41%. The ex-dividend date is Wednesday, July 30th. West Pharmaceutical Services's payout ratio is presently 13.19%.</p>
<div class="lb-trans"><p>该公司最近还宣布了一项季度股息，将于 8 月 6 日（星期三）支付。7 月 30 日（星期三）登记的股东将获得每股 0.21 美元的股息。这相当于年化股息为 0.84 美元，收益率为 0.41%。除息日期为 7 月 30 日（星期三）。西方制药服务的派息比率目前为 13.19%。</p>
</div><h2>Analyst Ratings Changes</h2>
<div class="lb-trans"><h2>分析师评级变动</h2>
</div><ul>
<li>Healthcare Stocks With at Least 30 Years of Dividend Increases</li>
</ul>
<div class="lb-trans"><ul>
<li>至少有 30 年股息增长的医疗保健股票</li>
</ul>
</div><p>WST has been the subject of several research analyst reports. Stephens raised West Pharmaceutical Services to a &#34;strong-buy&#34; rating in a research report on Monday, April 21st. Wall Street Zen lowered West Pharmaceutical Services from a &#34;buy&#34; rating to a &#34;hold&#34; rating in a research report on Thursday, February 27th. Citigroup reaffirmed a &#34;buy&#34; rating on shares of West Pharmaceutical Services in a research report on Thursday. Evercore ISI initiated coverage on West Pharmaceutical Services in a research report on Tuesday, March 18th. They set an &#34;outperform&#34; rating and a $275.00 target price for the company. Finally, KeyCorp decreased their target price on West Pharmaceutical Services from $470.00 to $325.00 and set an &#34;overweight&#34; rating for the company in a research report on Friday, February 14th. Two investment analysts have rated the stock with a hold rating, six have given a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat.com, West Pharmaceutical Services currently has an average rating of &#34;Moderate Buy&#34; and an average price target of $332.50.</p>
<div class="lb-trans"><p>WST 已成为几份研究分析师报告的主题。Stephens 在 4 月 21 日（星期一）的研究报告中将西方制药服务的评级上调至 “强力买入”。华尔街 Zen 在 2 月 27 日（星期四）的研究报告中将西方制药服务的评级从 “买入” 下调至 “持有”。花旗集团在周四的研究报告中重申了对西方制药服务股票的 “买入” 评级。Evercore ISI 在 3 月 18 日（星期二）的研究报告中开始覆盖西方制药服务，并为该公司设定了 “跑赢大盘” 的评级和 275.00 美元的目标价。最后，KeyCorp 在 2 月 14 日（星期五）的研究报告中将西方制药服务的目标价从 470.00 美元下调至 325.00 美元，并为该公司设定了 “增持” 评级。两位投资分析师对该股票给予了 “持有” 评级，六位给予了 “买入” 评级，一位给予了 “强力买入” 评级。根据 MarketBeat.com 的数据，西方制药服务目前的平均评级为 “适度买入”，平均目标价为 332.50 美元。</p>
</div><p><strong>View Our Latest Analysis on West Pharmaceutical Services</strong></p>
<div class="lb-trans"><p><strong>查看我们对西方制药服务的最新分析</strong></p>
</div><h2>West Pharmaceutical Services Company Profile</h2>
<div class="lb-trans"><h2>西方制药服务公司简介</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>（免费报告）</p>
</div><p>West Pharmaceutical Services, Inc designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products.</p>
<div class="lb-trans"><p>西方制药服务公司设计、制造和销售用于注射药物和医疗产品的封闭和输送系统，业务覆盖美洲、欧洲、中东、非洲和亚太地区。该公司分为两个部门，专有产品和合同制造产品。</p>
</div><h2>See Also</h2>
<div class="lb-trans"><h2>另见</h2>
</div><ul>
<li>Five stocks we like better than West Pharmaceutical Services</li>
<li>The How And Why of Investing in Oil Stocks</li>
<li>Workday Stock Price Implosion: An Automatic Buy for AI Investors</li>
<li>Uptrend Stocks Explained: Learn How to Trade Using Uptrends</li>
<li>MercadoLibre Is Soaring—Should You Wait for a Better Entry?</li>
<li>Expert Stock Trading Psychology Tips</li>
<li>Doubt the Market? 3 Stocks to Rideout Fear, Uncertainty and Doubt</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们更看好的股票，胜过西方制药服务</li>
<li>投资石油股票的方式和原因</li>
<li>Workday 股价暴跌：对 AI 投资者来说是自动买入</li>
<li>上升趋势股票解析：学习如何利用上升趋势进行交易</li>
<li>MercadoLibre 股价飙升——你应该等待更好的入场时机吗？</li>
<li>专家股票交易心理技巧</li>
<li>对市场有疑虑？3 只股票可应对恐惧、不确定性和怀疑</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVdTVA" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NYSE&amp;Symbol=WST"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，旨在为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。请将有关此故事的任何问题或评论发送至 contact@marketbeat.com.</em></p>
</div><h2>Should You Invest $1,000 in West Pharmaceutical Services Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在西氏医药服务吗？</h2>
</div><p>Before you consider West Pharmaceutical Services, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑西氏医药服务之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and West Pharmaceutical Services wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只股票，顶级分析师正在悄悄地向客户推荐在更广泛的市场注意到之前购买……而西氏医药服务并不在名单上。</p>
</div><p>While West Pharmaceutical Services currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然西氏医药服务目前在分析师中获得了买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

俄亥俄州公共雇员退休系统出售了 3,722 股西氏医药服务公司（NYSE:WST）的股票